Comparison of selective retinoic acid receptor- and retinoic X receptor-mediated efficacy, tolerance, and survival in cutaneous t-cell lymphoma

Journal of the American Academy of Dermatology
Christiane QuerfeldTimothy Kuzel

Abstract

Primary cutaneous T-cell lymphomas are non-Hodgkin's lymphomas with varied clinical presentation and prognosis. The most common subtypes of cutaneous T-cell lymphomas are the epidermotropic variants mycosis fungoides and Sézary syndrome. Treatment of mycosis fungoides has encompassed a variety of modalities including the use of retinoids with several studies evaluating their efficacy. The reported benefits and duration of response have varied in published data. The biological effect of retinoids is mediated by specific receptor families, retinoic acid receptor (RAR) and retinoic X receptor (RXR), with subsequently altered gene expression. There are no data available on cutaneous T-cell lymphomas that compare RAR and RXR retinoids. The objective of our retrospective, nonrandomized, single-center study was to compare the response, survival outcomes, and toxic effects in our phase II trial of the RAR-specific retinoid, all-trans retinoic acid, with clinical use of the RXR-specific retinoid, bexarotene, in patients with mycosis fungoides/Sézary syndrome who have relapsed. There was no statistical difference in response rates (12% vs 21%), response duration (20.5 vs 7.3 months), event-free survival time (4 vs 5 months), or median su...Continue Reading

References

Feb 1, 1991·Journal of the American Academy of Dermatology·R M KnoblerM Micksche
Feb 1, 1987·Archives of Dermatology·J F KesslerF L Meyskens
Jul 1, 1983·The British Journal of Dermatology·A L ClaudyJ C Le Petit
Jan 1, 1993·Acta Haematologica·B DrenoP Litoux
May 1, 1997·Leukemia & Lymphoma·M KizakiY Ikeda
May 20, 1999·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·F E FoxA H Rook
Jun 1, 2000·Current Pharmaceutical Design·S Nagpal, R A Chandraratna
May 15, 2003·Hematology·Vikas GuptaArmand Keating
Jun 24, 2003·Blood Reviews·Christiane QuerfeldSteven T Rosen
Jul 1, 2005·Journal of Cutaneous Medicine and Surgery·Judy HuSteven R Feldman
Jan 18, 2006·The Journal of Investigative Dermatology·Rakhshandra TalpurMadeleine Duvic
Mar 21, 2007·Journal of the American Academy of Dermatology·Christiane QuerfeldTimothy M Kuzel
Jun 20, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Elise A OlsenMadeleine Duvic
Dec 16, 2011·Journal of the European Academy of Dermatology and Venereology : JEADV·A C HüskenM Schiller
Nov 29, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D J StrausP L Myskowski

❮ Previous
Next ❯

Citations

Dec 3, 2009·Clinical Lymphoma & Myeloma·Pierluigi Porcu, Henry K Wong
Feb 19, 2009·The British Journal of Dermatology·R A AbbottJ J Scarisbrick
Jul 11, 2008·American Journal of Hematology·Srivalli GopaluniBernard J Poiesz
Oct 4, 2006·Dermatologic Therapy·Chunlei Zhang, Madeleine Duvic
Aug 23, 2012·International Journal of Dermatology·Uwe Wollina
Jan 21, 2014·The Journal of Dermatology·Keiji IwatsukiUNKNOWN Japanese Skin Cancer Society - Lymphoma Study Group
Mar 7, 2006·Seminars in Oncology·Rudolf Stadler, Almut Kremer
Jan 21, 2014·Journal of the American Academy of Dermatology·Sarah I JawedChristiane Querfeld
Dec 30, 2014·Molecular Aspects of Medicine·Alessandra di MasiClara Nervi
Apr 26, 2006·Expert Opinion on Pharmacotherapy·Christiane QuerfeldJoan Guitart
Feb 1, 2015·Journal of the American Academy of Dermatology·Johannah ValentineMario E Lacouture
Oct 27, 2016·British Journal of Haematology·Belen Rubio-GonzalezChristiane Querfeld
Jun 12, 2018·The Journal of Dermatological Treatment·Iris Amitay-LaishEmmilia Hodak
Jun 2, 2005·Current Opinion in Hematology·Christiane QuerfeldTimothy M Kuzel
Apr 7, 2007·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Yuxin Li, Powel H Brown
Apr 16, 2014·American Journal of Therapeutics·Malgorzata Sokolowska-WojdyloWojciech Jurczak
Nov 25, 2006·Hematology·Steven T Rosen, Christiane Querfeld
Dec 14, 2018·Frontiers in Pharmacology·Daniel HeudoblerAlbrecht Reichle
Jul 17, 2007·Toxicological Sciences : an Official Journal of the Society of Toxicology·Thomas L HornDavid L McCormick
Nov 27, 2020·Haematologica·Orsola Di MartinoJohn S Welch
Sep 28, 2021·Current Treatment Options in Oncology·Caitlin M BrumfielAaron R Mangold

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.